Laboratory Question for the Week of July 7, 2025
We are a hospital-based laboratory. Can we charge Medicare for handling fees to send samples to a reference lab using code 99001?
We are a hospital-based laboratory. Can we charge Medicare for handling fees to send samples to a reference lab using code 99001?
Are there any code edits that we should be aware of when applying LT and RT modifiers?
If both low-risk and high-risk HPV types are performed in a single assay, how would we code?
When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?
We are still confused about when to use or if to use the LT or RT modifier. Do you have a formula that we could apply based on a scenario?
Do you have any additional guidelines for modifiers LT and RT?
What is the procedure code when a specific antigen test is ordered as a diagnostic test based on a sign or symptom?
Can you provide more clarity for 37215?
When would we report modifiers LT and RT?
As a follow-up to last week’s question, if an embolic protection device cannot be used, which code do we report between the two?
Why is it important to distinguish between codes 81025 and 84703 when coding pregnancy tests?
What physician requirements are necessary to report code 88172?
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.




CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24Â